User:CFCF/sandbox/44
From Wikipedia, the free encyclopedia
Speculative proposals and early-stage research should not be cited to imply wide acceptance. For example, results of an early-stage clinical trial would not be appropriate in the Treatment section on a disease because future treatments have little bearing on current practice. The results might – in some cases – be appropriate for inclusion in an article specifically dedicated to the treatment in question or to the researchers or businesses involved in it. Such information, particularly when citing secondary sources, may be appropriate in research sections of disease articles. To prevent misunderstanding, the text should clearly identify the level of research cited (e.g., "first-in-human safety testing").
Several formal systems exist for assessing the quality of available evidence on medical subjects.[1][2] "Assessing evidence quality" means editors should determine quality of the type of study. Respect the levels of evidence: Do not reject a high-quality type of study (e.g., a meta-analysis) in favor of a source from lower levels of evidence (e.g., any primary source) because of personal objections to the inclusion criteria, references, funding sources, or conclusions in the higher-level source.
"Assessing evidence quality" means editors should determine quality of the type of source and quality of the publication. Editors should not perform detailed academic peer review.